Immutep stock slips after share offering (NASDAQ:IMMP)
Daniel Grzelj ADRs of Immutep Limited (Nasdaq: IMP) fell on Wednesday after the Australian biotechnology company announced the conclusion of a share offering targeting institutional investors. The Sydney-based cancer drug developer said…
